{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:15:15Z","timestamp":1790716515194,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"K. C. Wong Magna Fund in Ningbo University"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30901802"],"award-info":[{"award-number":["30901802"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81201050"],"award-info":[{"award-number":["81201050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Zhejiang Province","award":["LY12H09002"],"award-info":[{"award-number":["LY12H09002"]}]},{"name":"Natural Science Foundation of Zhejiang Province","award":["LQ12H09001"],"award-info":[{"award-number":["LQ12H09001"]}]},{"name":"Innovative Research Team of Ningbo","award":["2009B21002"],"award-info":[{"award-number":["2009B21002"]}]},{"name":"Natural Science Foundation of Ningbo","award":["2012A610249"],"award-info":[{"award-number":["2012A610249"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.neuropharm.2014.04.021","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T16:30:15Z","timestamp":1400085015000},"page":"131-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Chronic resveratrol treatment exerts antihyperalgesic effect and corrects co-morbid depressive like behaviors in mice with mononeuropathy: Involvement of serotonergic system"],"prefix":"10.1016","volume":"85","author":[{"given":"Xin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-Geng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2014.04.021_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0304-3959(88)90198-4","article-title":"Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain","volume":"33","author":"Arn\u00e9r","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/01.psy.0000204851.15499.fc","article-title":"Comorbid depression, chronic pain, and disability in primary care","volume":"68","author":"Arnow","year":"2006","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib3","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuroscience.2011.12.041","article-title":"Tests and models of nociception and pain in rodents","volume":"211","author":"Barrot","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/np300529x","article-title":"Evidence for the analgesic activity of resveratrol in acute models of nociception in mice","volume":"76","author":"Bazzo","year":"2013","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib6","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ejpain.2008.01.010","article-title":"Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice","volume":"12","author":"Benbouzid","year":"2008","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A\u00a0peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/ars.2007.1926","article-title":"Analgesic resveratrol?","volume":"10","author":"Bertelli","year":"2008","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuropharm.2008.06.032","article-title":"Desipramine potentiation of the acute depressant effects of ethanol: modulation by alpha2-adrenoreceptors and stress","volume":"55","author":"Boyce-Rustay","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/ALN.0b013e3182657b3e","article-title":"Depressive-like states heighten the aversion to painful stimuli in a rat model of comorbid chronic pain and depression","volume":"117","author":"Bravo","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pain.2010.03.007","article-title":"Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity","volume":"149","author":"Brenchat","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib12","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.neuroscience.2010.10.030","article-title":"Enhanced nociceptive responding in two rat models of depression is associated with alterations in monoamine levels in discrete brain regions","volume":"171","author":"Burke","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib13","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.288.5464.306","article-title":"Impaired nociception and pain sensation in mice lacking the capsaicin receptor","volume":"288","author":"Caterina","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib14","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1476-5381.2009.00510.x","article-title":"Beta2-adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment","volume":"158","author":"Choucair-Jaafar","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib15","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/HYPERTENSIONAHA.109.133397","article-title":"Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats","volume":"54","author":"Csiszar","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jad.2006.01.007","article-title":"Comorbid painful physical symptoms and depression: prevalence, work loss, and help seeking","volume":"92","author":"Demyttenaere","year":"2006","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib17","first-page":"1389","article-title":"Resveratrol: a unique antioxidant offering a multi-mechanistic approach for treating aging skin","volume":"12","author":"Farris","year":"2013","journal-title":"J.\u00a0Drugs Dermatol."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pbb.2013.10.028","article-title":"Antidepressant-like effect of resveratrol: involvement of antioxidant effect and peripheral regulation on HPA axis","volume":"114-115","author":"Ge","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1399-6576.2007.01486.x","article-title":"Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey","volume":"52","author":"Gustorff","year":"2008","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1476-5381.1957.tb01354.x","article-title":"Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse","volume":"12","author":"Haley","year":"1957","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A\u00a0new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11011-013-9426-y","article-title":"Piperine potentiates the antidepressant-like effect of trans-resveratrol: involvement of monoaminergic system","volume":"28","author":"Huang","year":"2013","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuropharm.2006.05.008","article-title":"Mu opioid receptor-dependent and independent components in effects of tramadol","volume":"51","author":"Ide","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib26","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/0006-2952(68)90066-X","article-title":"Some observations upon a new inhibitor of monoamine oxidase in brain tissue","volume":"17","author":"Johnston","year":"1968","journal-title":"Biochem Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib27","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1172\/JCI61884","article-title":"Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression","volume":"122","author":"Kim","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib28","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1176\/appi.ajp.2009.10030434","article-title":"Linking molecules to mood: new insight into the biology of depression","volume":"167","author":"Krishnan","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib29","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.2174\/09298673113209990151","article-title":"Neuroprotection by resveratrol in diabetic neuropathy: concepts & mechanisms","volume":"20","author":"Kumar","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib30","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1158\/0008-5472.CAN-09-1266","article-title":"Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target","volume":"69","author":"Lee","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib31","first-page":"644","article-title":"L-type calcium channel blockers enhance 5-HTP-induced antinociception in mice","volume":"25","author":"Liang","year":"2004","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbr.2014.01.039","article-title":"Resveratrol reverses the effects of chronic unpredictable mild stress on behavior, serum corticosterone levels and BDNF expression in rats","volume":"264","author":"Liu","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pnpbp.2013.10.017","article-title":"Resveratrol prevents impaired cognition induced by chronic unpredictable mild stress in rats","volume":"49","author":"Liu","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib34","series-title":"Classification of Chronic Pain","author":"Merksey","year":"1994"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib35","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.tips.2006.05.004","article-title":"Antidepressants and pain","volume":"27","author":"Mic\u00f3","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","article-title":"Descending control of pain","volume":"66","author":"Millan","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib37","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1017\/S0007114511007227","article-title":"Anti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide-induced NF-\u03baB activation in Caco-2 and SW480 human colon cancer cells","volume":"108","author":"Panaro","year":"2012","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib38","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.pbb.2008.05.024","article-title":"Spinal nerve ligation reduces nitric oxide synthase activity and expression: effect of resveratrol","volume":"90","author":"P\u00e9rez-Severiano","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib39","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2009.01.009","article-title":"5-HT1A receptor function in major depressive disorder","volume":"88","author":"Savitz","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib41","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ptr.2070","article-title":"Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha","volume":"21","author":"Sharma","year":"2007","journal-title":"Phytother. Res."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1472-8206.2006.00455.x","article-title":"Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain","volume":"21","author":"Sharma","year":"2007","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib43","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1213\/01.ANE.0000160582.25368.B9","article-title":"The antiallodynic and antihyperalgesic effects of neurotropin in mice with spinal nerve ligation","volume":"101","author":"Suzuki","year":"2005","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.bjp.0707125","article-title":"The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems","volume":"150","author":"Tanabe","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib45","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/070674370805300403","article-title":"Epidemiology of chronic pain with psychological comorbidity: prevalence, risk, course, and prognosis","volume":"53","author":"Tunks","year":"2008","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2013.01.074","article-title":"Multiple roles of serotonin in pain control mechanisms \u2013 implications of 5-HT7 and other 5-HT receptor types","volume":"716","author":"Viguier","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib47","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.neuropharm.2012.07.023","article-title":"GABA, but not opioids, mediates the anti-hyperalgesic effects of 5-HT7 receptor activation in rats suffering from neuropathic pain","volume":"63","author":"Viguier","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib48","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pnpbp.2013.02.005","article-title":"The antinociceptive effect of reversible monoamine oxidase-A inhibitors in a mouse neuropathic pain model","volume":"44","author":"Villarinho","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pain.2009.03.013","article-title":"Non-steroidal anti-inflammatory drugs for neuropathic pain: how do we explain continued widespread use?","volume":"143","author":"Vo","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib50","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/j.pain.2012.08.016","article-title":"Exacerbated mechanical hyperalgesia in rats with genetically predisposed depressive behavior: role of melatonin and NMDA receptors","volume":"153","author":"Wang","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.euroneuro.2010.02.013","article-title":"Antidepressant-like effect of trans-resveratrol: involvement of serotonin and noradrenaline system","volume":"20","author":"Xu","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib52","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.biopsych.2011.07.017","article-title":"A\u00a0time-dependent history of mood disorders in a murine model of neuropathic pain","volume":"70","author":"Yalcin","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib53","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.nbd.2008.11.003","article-title":"Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain","volume":"33","author":"Yalcin","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/AAP.0b013e3182795b23","article-title":"Resveratrol facilitates pain attenuation in a rat model of neuropathic pain through the activation of spinal Sirt1","volume":"38","author":"Yin","year":"2013","journal-title":"Reg. Anesth. Pain Med."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1744-8069-9-3","article-title":"Modulation of TRP channels by resveratrol and other stilbenoids","volume":"9","author":"Yu","year":"2013","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib56","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jpsychires.2012.10.018","article-title":"Antidepressant-like effect of trans-resveratrol in chronic stress model: behavioral and neurochemical evidences","volume":"47","author":"Yu","year":"2013","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2014.04.021_bib57","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.neuropharm.2011.08.050","article-title":"Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: descending monoamine system and opioid receptors are differentially involved","volume":"62","author":"Zhao","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.04.021_bib58","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bbr.2011.12.017","article-title":"The antidepressant-like effect of fisetin involves the serotonergic and noradrenergic system","volume":"228","author":"Zhen","year":"2012","journal-title":"Behav. Brain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814001579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814001579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T07:43:32Z","timestamp":1568965412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390814001579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":58,"alternative-id":["S0028390814001579"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.04.021","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic resveratrol treatment exerts antihyperalgesic effect and corrects co-morbid depressive like behaviors in mice with mononeuropathy: Involvement of serotonergic system","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.neuropharm.2014.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}